Recombinant Neisseria meningitidis serogroup C ATP synthase subunit b (atpF)

What is ATP synthase subunit b (atpF) in Neisseria meningitidis and why is it significant?

ATP synthase subunit b (atpF) is a critical component of the bacterial F₁F₀-ATP synthase complex in N. meningitidis, which is responsible for energy production through oxidative phosphorylation. This membrane-bound protein forms part of the stator, connecting the catalytic F₁ portion to the membrane-embedded F₀ portion. In pathogenic bacteria like N. meningitidis serogroup C, ATP synthase is essential for survival and virulence, potentially serving as a target for antimicrobial development. While most research has focused on other membrane proteins like transferrin binding proteins (TbpA and TbpB) , understanding ATP synthase components provides valuable insights into bacterial metabolism and pathogenesis.

How does N. meningitidis atpF differ structurally from ATP synthase components in other bacteria?

N. meningitidis atpF exhibits the characteristic bipartite structure seen in bacterial b subunits, with an N-terminal transmembrane domain and a larger C-terminal cytoplasmic domain that forms part of the peripheral stalk. While the core structure is conserved across bacteria, sequence analysis reveals specific variations in the cytoplasmic domain that may affect interactions with other ATP synthase components. These variations could influence complex stability and regulatory properties under different environmental conditions. Structural comparisons with ATP synthase components from other organisms, such as the ATP synthase subunit c from spinach chloroplasts , show conservation of functional domains despite sequence divergence.

What genetic organization surrounds the atpF gene in N. meningitidis serogroup C?

The atpF gene in N. meningitidis serogroup C is typically located within the atp operon, which encodes the various subunits of ATP synthase. This operon organization is similar to what is observed in other bacteria, though specific gene arrangement and regulatory elements may differ. The operon structure often reflects the assembly sequence and stoichiometry of the ATP synthase complex. In N. meningitidis, this organization may have evolved for coordinated expression under specific environmental conditions encountered during infection.

What expression systems are most effective for recombinant N. meningitidis atpF?

Based on strategies employed for other membrane proteins from N. meningitidis and ATP synthase components, E. coli expression systems offer the most viable platform for atpF production. Vector selection significantly impacts expression success, with several options showing varying effectiveness:

Co-expression with chaperone proteins (DnaK, DnaJ, and GrpE) has been demonstrated to substantially increase quantities of difficult-to-express membrane proteins . For atpF specifically, fusion to MBP appears most promising as this approach has succeeded with other ATP synthase subunits that were otherwise toxic or poorly expressed.

What cloning strategies are optimal for N. meningitidis atpF expression?

The optimal cloning strategy for N. meningitidis atpF should consider codon optimization, fusion partners, and vector design. Based on approaches used for other ATP synthase components:

• Gene synthesis with optimized codons for E. coli is recommended, as demonstrated with other recombinant proteins .

• Incorporation of appropriate restriction sites (such as NdeI at the start codon and XhoI at the 3' end) facilitates precise insertion into expression vectors .

• Vector selection should consider inducible promoter systems (T7 or tac) with tight regulation to control potential toxicity.

• For membrane proteins like atpF, fusion partners that enhance solubility and expression are crucial - MBP fusion has shown particular success with ATP synthase components .

• Inclusion of cleavable affinity tags (His₆, FLAG) enables purification while allowing tag removal for functional studies.

A synthetic gene approach using overlapping oligonucleotides, as employed for the ATP synthase c subunit , provides flexibility to incorporate these design elements simultaneously.

How can I optimize purification of recombinant N. meningitidis atpF?

Purification of recombinant N. meningitidis atpF requires a carefully designed protocol addressing its membrane protein nature:

Purification Protocol:

• Cell Lysis: French press or sonication in buffer containing protease inhibitors.

• Membrane Fraction Isolation: Ultracentrifugation of clarified lysate.

• Detergent Solubilization: Critical step using mild detergents (DDM, LDAO) to extract atpF while maintaining native structure.

• Affinity Chromatography: Utilizing fusion tags (His₆, MBP) for initial capture.

• Secondary Purification: Size exclusion chromatography to remove aggregates and achieve homogeneity.

Maintaining protein stability throughout purification is critical. Addition of stabilizing agents like glycerol (10-15%) and reducing agents (DTT or β-mercaptoethanol) helps preserve structural integrity during storage .

What methods are most reliable for verifying proper folding of recombinant N. meningitidis atpF?

Verifying proper folding of recombinant N. meningitidis atpF requires multiple complementary approaches:

• Circular Dichroism (CD) Spectroscopy: Assesses secondary structure content, particularly alpha-helical content expected in atpF.

• Thermal Stability Analysis: Differential scanning fluorimetry or CD thermal melts can evaluate protein stability and folding quality.

• Limited Proteolysis: Properly folded proteins typically show discrete digestion patterns reflecting structured domains.

• Native PAGE: Migration patterns can distinguish between properly folded protein and aggregates.

• Interaction Studies: Binding assays with known partner subunits (particularly delta subunit) using size exclusion chromatography or surface plasmon resonance.

• Reconstitution Experiments: Assembly with other ATP synthase components to form partial or complete complexes.

These methods collectively provide strong evidence for native-like structure of the recombinant protein, essential before proceeding to functional or structural studies.

How can I assess the functionality of recombinant N. meningitidis atpF?

Assessing functionality of recombinant N. meningitidis atpF presents unique challenges since the b subunit alone does not possess enzymatic activity. Functional evaluation requires:

• Reconstitution Studies: Incorporating atpF into liposomes or nanodiscs along with other ATP synthase components to reconstruct partial or complete complexes.

• Binding Assays: Quantitative measurement of interactions with natural partners (particularly delta and a subunits) using techniques like isothermal titration calorimetry or microscale thermophoresis.

• ATP Synthesis/Hydrolysis Assays: Testing whether inclusion of recombinant atpF enables or enhances ATP synthase activity in reconstituted systems.

• Complementation Studies: Expressing N. meningitidis atpF in E. coli atpF deletion strains to assess functional substitution.

• Structural Probes: Using cross-linking and mass spectrometry to verify correct positioning within the ATP synthase complex.

A malachite green phosphate detection assay, similar to that described for ATP sulfurylase , can be adapted to measure ATP hydrolysis activity of reconstituted complexes containing atpF.

What computational approaches help predict structure-function relationships in N. meningitidis atpF?

Several computational approaches provide valuable insights into atpF structure-function relationships:

• Homology Modeling: Using crystal structures of ATP synthase b subunits from model organisms as templates.

• Molecular Dynamics Simulations: Exploring conformational flexibility and stability in membrane environments.

• Coevolution Analysis: Identifying residue pairs that have co-evolved, suggesting structural or functional importance.

• Conservation Mapping: Identifying highly conserved residues across species, which often correlate with functional importance.

• Protein-Protein Docking: Predicting interaction interfaces with other ATP synthase components.

• Electrostatic Surface Analysis: Particularly important for the charged cytoplasmic domain involved in stator function.

These in silico approaches complement experimental data and can guide the design of targeted mutations to test hypotheses about structure-function relationships.

How does N. meningitidis atpF contribute to bacterial pathogenesis?

While direct evidence for atpF's role in pathogenesis is limited, several mechanistic connections can be inferred:

• Energy Metabolism: As part of ATP synthase, atpF contributes to energy production necessary for virulence factor expression and bacterial survival during infection.

• pH Adaptation: ATP synthase can function in reverse as an ATPase to maintain intracellular pH homeostasis, potentially aiding survival in acidic microenvironments.

• Stress Response: The ATP synthase complex may play roles in adapting to stress conditions encountered during infection.

• Potential Interactions: Some bacterial ATP synthase components have been reported to moonlight with additional functions beyond bioenergetics.

Research approaches to explore these connections include gene knockout studies, expression analysis under infection-relevant conditions, and in vivo infection models comparing wild-type and atpF-modified strains.

How can structural studies of recombinant N. meningitidis atpF inform drug design?

Structural studies of recombinant N. meningitidis atpF can inform antimicrobial drug design through several approaches:

• Structure Determination: X-ray crystallography or cryo-electron microscopy of atpF alone or in complex with binding partners can reveal atomic details of potential drug binding sites.

• Identification of Essential Interfaces: Mapping critical interaction surfaces between atpF and other ATP synthase components identifies potential targets for disruption.

• Virtual Screening: Computational docking of compound libraries against identified binding pockets.

• Fragment-Based Drug Design: Using structural data to guide development of small molecule inhibitors targeting specific atpF functions.

• Comparative Analysis: Identifying structural differences between bacterial and human ATP synthase b subunits to enable selective targeting.

The unique structural features of atpF may provide opportunities for developing narrow-spectrum antibiotics targeting N. meningitidis specifically, addressing the growing problem of antibiotic resistance.

What are the challenges in crystallizing recombinant N. meningitidis atpF?

Crystallization of recombinant N. meningitidis atpF faces several challenges typical of membrane proteins:

• Protein Stability: Maintaining stability throughout purification and crystallization trials.

• Detergent Selection: Identifying detergents that maintain native structure while permitting crystal contacts.

• Conformational Heterogeneity: The extended structure of atpF's cytoplasmic domain may adopt multiple conformations, hindering crystallization.

• Expression Yield: Obtaining sufficient quantities of pure, homogeneous protein for extensive crystallization trials.

• Crystal Packing: The elongated shape of atpF complicates formation of well-ordered crystal lattices.

Alternative approaches include:

• Crystallization of truncated constructs focusing on individual domains

• Lipidic cubic phase crystallization for the transmembrane region

• Co-crystallization with binding partners or antibody fragments to stabilize specific conformations

• Cryo-electron microscopy as an alternative to crystallography

How can I assess the immunogenicity of recombinant N. meningitidis atpF?

Assessing immunogenicity of recombinant N. meningitidis atpF requires a comprehensive approach similar to that used for other meningococcal antigens :

In vitro Assessment:

• Antibody Generation: Immunization of animals (typically mice or rabbits) with purified recombinant atpF.

• ELISA: Quantification of specific antibody titers and subclass distribution.

• Western Blotting: Confirmation of antibody specificity against native and recombinant atpF.

• Surface Binding: Flow cytometry to determine if antibodies bind intact bacteria, indicating surface accessibility.

• Functional Assays: Serum bactericidal assays (SBA) and opsonophagocytic killing assays to assess protective potential .

In vivo Assessment:

• Challenge Studies: Immunization of mice followed by challenge with N. meningitidis to evaluate protection, similar to approaches used for TbpA and TbpB evaluation .

• Cross-Protection: Testing protection against heterologous strains to assess cross-reactivity .

This comprehensive approach determines whether atpF generates functionally relevant immune responses despite its presumed inner membrane localization.

How does atpF from N. meningitidis serogroup C compare with other serogroups?

Comparative analysis of atpF across N. meningitidis serogroups reveals important insights:

While ATP synthase components show high conservation compared to surface antigens, subtle variations between serogroups may impact complex assembly efficiency or regulatory properties. These differences could contribute to serogroup-specific metabolic adaptations but are unlikely to directly influence serogroup-specific pathogenesis like capsular polysaccharides do .

How can I resolve conflicting data on N. meningitidis atpF function?

Resolving conflicting data on N. meningitidis atpF function requires systematic investigation:

• Critical Evaluation of Methodologies:

  • Compare protein expression systems and constructs used

  • Assess purification methods and protein quality metrics

  • Evaluate functional assay conditions and detection methods

• Strain-Specific Analysis:

  • Sequence the atpF gene from the specific strains used

  • Consider genomic context and potential regulatory differences

• Experimental Context Considerations:

  • Reconstitution systems (detergents, lipids, nanodiscs)

  • Buffer conditions (pH, ionic strength, divalent cations)

  • Presence of interaction partners

• Multi-Technique Validation:

  • Apply complementary techniques to verify findings

  • Consider both structural and functional approaches

• Direct Comparative Studies:

  • Obtain materials from conflicting studies if possible

  • Perform side-by-side experiments under identical conditions

This systematic approach can identify the sources of discrepancies and establish consensus on atpF function.

What statistical methods are appropriate for analyzing ATP synthase activity data?

Appropriate statistical analysis of ATP synthase activity data depends on experimental design:

• For Comparing Activity Between Conditions:

  • Two conditions: Student's t-test (parametric) or Mann-Whitney U test (non-parametric)

  • Multiple conditions: ANOVA with appropriate post-hoc tests (Tukey, Bonferroni) or Kruskal-Wallis (non-parametric)

• For Enzyme Kinetics:

  • Non-linear regression for fitting Michaelis-Menten or Hill equations

  • Bootstrap analysis for robust parameter estimation and confidence intervals

• For Time-Course Experiments:

  • Repeated measures ANOVA or mixed models

  • Area under the curve (AUC) analysis followed by appropriate comparison tests

• For Structure-Function Correlations:

  • Multiple regression or partial least squares regression

  • Principal component analysis for complex datasets

• Sample Size Determination:

  • Power analysis based on expected effect size and variability

  • Minimum n=3 independent biological replicates, preferably n≥5

Transparent reporting of statistical methods, including exact p-values and effect sizes, is essential for reproducibility.

How does research on N. meningitidis atpF complement other meningococcal vaccine development approaches?

Research on N. meningitidis atpF complements existing vaccine approaches in several ways:

• Antigen Diversity: While current vaccines target capsular polysaccharides or outer membrane proteins like transferrin binding proteins , ATP synthase components represent a distinct class of potential antigens.

• Conservation Across Strains: Unlike variable surface antigens, ATP synthase components show high conservation, potentially offering broader protection across strains and serogroups.

• T-Cell Responses: As a protein antigen, atpF can stimulate T-cell responses in addition to antibody production, potentially enhancing vaccine efficacy.

• Combination Approaches: Including atpF alongside established antigens like TbpA and TbpB could create more comprehensive protection through synergistic immune responses.

• Novel Adjuvant Development: Structure-function studies of atpF could inform development of ATP synthase-targeting adjuvants that enhance vaccine efficacy.

While accessibility may limit direct antibody targeting of atpF in intact bacteria, understanding its structure and function contributes to comprehensive meningococcal research.

What emerging technologies might advance N. meningitidis atpF research?

Several emerging technologies hold promise for advancing N. meningitidis atpF research:

• Cryo-Electron Microscopy: Enables high-resolution structural determination without crystallization, particularly valuable for membrane proteins like atpF.

• Native Mass Spectrometry: Allows analysis of intact membrane protein complexes, providing insights into ATP synthase assembly and stoichiometry.

• Single-Molecule Techniques: FRET and optical tweezers can monitor real-time conformational changes during ATP synthase function.

• Nanodiscs and Styrene-Maleic Acid Lipid Particles (SMALPs): Improved membrane mimetics for functional and structural studies of membrane proteins without detergents.

• CRISPR-Cas9 Genome Editing: Enables precise genetic manipulation of N. meningitidis to study atpF function in vivo.

• Microfluidic Approaches: High-throughput screening of conditions for expression, purification, and crystallization.

• Computational Advances: Improved molecular dynamics simulations and machine learning approaches for structure prediction and drug design.

These technologies collectively offer new avenues for understanding atpF structure, function, and potential as a therapeutic target.